Page last updated: 2024-09-03

2-pyrrolino-dox and Adenocarcinoma Of Kidney

2-pyrrolino-dox has been researched along with Adenocarcinoma Of Kidney in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, B; Engel, JB; Gaiser, T; Halmos, G; Keller, G; Nagy, A; Schally, AV	1
Baker, B; Engel, JB; Halmos, G; Keller, G; Nagy, A; Schally, AV	1

Other Studies

2 other study(ies) available for 2-pyrrolino-dox and Adenocarcinoma Of Kidney

Article	Year
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-01, Volume: 11, Issue:15 Topics: Animals; Antineoplastic Agents; Binding Sites; Blotting, Western; Carcinoma, Renal Cell; Cell Differentiation; Cell Line, Tumor; DNA, Complementary; Doxorubicin; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Kinetics; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptides; Protein Binding; Pyrroles; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors	2005
Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas. Cancer, 2005, Nov-15, Volume: 104, Issue:10 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bombesin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Transplantation; Chemokines, CC; Disease Models, Animal; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Receptors, Bombesin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2005

Article

Year

Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-01, Volume: 11, Issue:15

Topics: Animals; Antineoplastic Agents; Binding Sites; Blotting, Western; Carcinoma, Renal Cell; Cell Differentiation; Cell Line, Tumor; DNA, Complementary; Doxorubicin; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Kinetics; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptides; Protein Binding; Pyrroles; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2005

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas.

Cancer, 2005, Nov-15, Volume: 104, Issue:10

Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bombesin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Transplantation; Chemokines, CC; Disease Models, Animal; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Receptors, Bombesin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2005